ADHD dementia risk quadruples, large study finds

A large new study of ADHD dementia risk finds that adults with ADHD face a sharply higher chance of developing cognitive impairment later in life. The research, led by the University of Pittsburgh School of Medicine and published in JAMA Psychiatry on October 7, 2026, analyzed health records and genetic data from nearly 190,000 adults enrolled in the National Institutes of Health's All of Us Research Program.

The team followed nearly 190,000 participants aged 50 and older over an average of about 10 years. Among the 3,026 participants with an ADHD diagnosis, 203 — or 6.7 percent — developed mild cognitive impairment or dementia during follow-up, compared with 3.4 percent of participants without ADHD, according to Medical Xpress, which reported on the study. After adjusting for age, sex, and other health conditions, people with ADHD showed a 4.6-fold higher hazard of developing cognitive impairment over time, a hazard ratio of 4.60.

The association held up under stricter tests. When the researchers further adjusted for physical illnesses, the elevated risk tied to ADHD remained 4.04 times higher, and after accounting for mental health conditions it still stood at 3.19 times higher. The risk of dementia alone was 3.07 times higher in the ADHD group, and the risk of mild cognitive impairment alone was 3.83 times higher. The study's published abstract confirms the headline figures, reporting the same hazard ratios in the primary and adjusted models.

Genetic data points in the same direction

Crucially, the elevated risk was not limited to people with a formal ADHD diagnosis. The researchers also calculated each participant's genetic risk score for ADHD, based on how many common genetic variants associated with the condition a person carries. People in the highest genetic risk category had a 35 percent greater chance of developing cognitive impairment than those in the lowest risk group — even without a documented ADHD diagnosis.

Senior author Tharick A. Pascoal, an associate professor of psychiatry and neurology at Pitt, said the convergence of the two lines of evidence strengthens the finding, noting that the same pattern appearing in medical records and in genetic data suggests the link is not simply an artifact of how ADHD is diagnosed. Co-author Douglas Teixeira Leffa, a psychiatry resident at the University of Pittsburgh Medical Center, said the study replicates patterns previously observed in other countries, now in a large U.S. sample, and adds genetic evidence on top.

The researchers also examined whether early, undetected dementia symptoms might simply be mistaken for ADHD before a formal cognitive diagnosis is made. The association remained statistically significant even when the team required at least eight years to pass between an ADHD diagnosis and the onset of cognitive impairment, making that explanation unlikely to account for the full effect.

ADHD made life with dementia measurably harder

The study found that ADHD compounded the burden of living with dementia. Among participants who developed cognitive impairment, those with a co-occurring ADHD diagnosis reported worse mental health, lower quality of life, and less social satisfaction than those with dementia alone, and they used about 20 percent more health care overall in the year following diagnosis.

Several open questions remain. The researchers did not determine whether ADHD medications, such as stimulants, might lower dementia risk over time, or whether managing cardiovascular health — already linked to both ADHD and dementia — could reduce the odds. The findings are observational, meaning they show an association but do not prove that ADHD causes dementia. The study builds on earlier work from the Pascoal lab, including a 2022 study that first linked ADHD genetic risk to Alzheimer's-related brain changes in cognitively unimpaired older adults.

The work lands as scientists race to build better early-detection tools for brain disorders, a field that has seen rapid progress — including, as GenZ NewZ has previously reported, a blood test sensor that spots early Parkinson's markers with 90.9 percent accuracy, and new ferritin cutoffs reshaping iron deficiency screening.

Why it matters

ADHD is one of the most common neurodevelopmental conditions, and it is widely underdiagnosed in adults. This study, the largest to combine clinical diagnoses and genetic data in the same population, suggests that a clearer picture of ADHD dementia risk could reshape how brain health is monitored in the millions of adults living with the condition — and that earlier cognitive screening for people with ADHD may become part of routine care.